Cloud-Clone pitches 5-HT ELISA kit for gut-brain axis research
Cloud-Clone Corp. is promoting a new serotonin ELISA kit designed to help researchers measure 5-HT more reliably in samples used for gut-brain axis, neuropsychiatry and gastrointestinal studies. The company says the kit is built to reduce oxidation, cross-reactivity and matrix interference, which are major problems in serotonin testing.
Why it matters: - Serotonin, or 5-hydroxytryptamine (5-HT), is a core signal in gut-brain axis research, and unreliable measurement can distort studies of mood, sleep, gastrointestinal function and immune balance. - Better 5-HT quantification matters for drug screening, disease modeling and translational research in neuropsychiatry, gastroenterology and toxicology. - The press release argues that common testing methods can miss subtle changes in trace-level 5-HT, creating weak or non-reproducible data.
What happened: - Cloud-Clone Corp. introduced its optimized 5-HT ELISA kit, Cat. No. CEA808Ge, as a research tool for quantifying serotonin in multiple biological samples. - The kit is positioned for use in human, rat and mouse studies. - The company says the assay is designed for gut-brain axis, neuropsychiatric, gastrointestinal, inflammatory and toxicology research.
The details: - 5-HT is described as a neurotransmitter with separate central and peripheral pools that serve different biological roles. - Central 5-HT is linked to emotional stability, cognition and sleep regulation. - Peripheral 5-HT is mostly produced in intestinal enterochromaffin cells and supports gastrointestinal motility, secretion and visceral sensitivity. - 5-HT is synthesized from tryptophan through enzymatic steps involving tryptophan hydroxylase and aromatic L-amino acid decarboxylase. - 5-HT is degraded mainly by monoamine oxidase into 5-hydroxyindole-3-acetic acid, or 5-HIAA. - The source text says 5-HT is chemically unstable and vulnerable to heat, light, freeze-thaw cycles and enzymatic activity. - Dopamine and norepinephrine can interfere with 5-HT measurement because of structural similarity. - The kit supports serum, plasma, brain tissue homogenate, intestinal tissue homogenate, cell culture supernatant and cerebrospinal fluid. - The assay is described as a competitive ELISA that does not require complex extraction, purification or derivatization. - The complete test is said to finish within three hours using a 96-well plate format. - Cloud-Clone says the kit uses specific monoclonal antibodies, anti-oxidation buffers, signal amplification and matrix-shielding components to improve specificity and stability. - The company says the kit offers high sensitivity and a broad linear range for low- and high-concentration samples. - The company says batch testing showed low intra-assay and inter-assay variation. - The release includes links to Cloud-Clone's official website, LinkedIn page, Instagram account, TikTok account, LinkedIn profile, and X account.
Between the lines: - The release is as much a product pitch as a technical argument for why serotonin assays fail in routine lab workflows. - Cloud-Clone is targeting a common research pain point: standard ELISA convenience versus the analytical problems created by serotonin's instability and the complexity of tissue and serum samples. - The emphasis on multi-matrix compatibility and high throughput suggests the kit is aimed at labs running batch animal studies and screening projects.
What's next: - Cloud-Clone says it will continue optimizing assay performance for neurotransmitters, metabolic molecules and inflammatory biomarkers. - Researchers seeking 5-HT quantification tools can obtain product specifications and technical support through the company's official channels. - The company says the kit is part of a broader portfolio of immunoassay reagents, antibodies, ELISA kits, primary cells and multiplex cytokine assay kits.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Science Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.